ArticleBMJ open2021

Cost-effectiveness analysis of 3 months of weekly rifapentine and isoniazid compared to isoniazid monotherapy in a Canadian arctic setting.

Christopher Pease et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.